For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Ofatumumab IV, | Ofatumumab 1000 mg IV Cycle 1 on day 1, 8, 15 and 22, Ofatumumab and Bortezomib: Ofatumumab 1000 mg IV Cycle 1 on day 1, 8, 15 and 22- in the induction phase Ofatumumab 1000 mg IV on day 1- will receive in the maintenance phase Patients will remain until progression | None | None | 1 | 10 | 10 | 10 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| infusion reaction | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| glucose | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| abdominal pain | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| shortness of breath | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| edema | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| fatigue | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| white blood cell decrease | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| general pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| rash | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| derm skin other | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| anemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| thrombocytopenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| neuropathy | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| neutropenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Red blodd cell | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Liver function test abnormalities | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| muscle aches | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| phosphorus | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| sweating | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| mood alteration | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| phlebitis | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| creatinine | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| dehydration | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hip pain | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| cough | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| back pain | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| heartburn | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| upper respiratory infection | SYSTEMATIC_ASSESSMENT | Investigations | None | View |